HeartSciences Inc. (HSCS) Stock

HeartSciences Inc. (HSCS) is a Healthcare stock trading at $1.83 (as of 2026-06-18), with a market capitalization of $6.67M and a trailing P/E of -0.3. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

HeartSciences Inc. develops AI-enhanced electrocardiography offerings, including an algorithm intended to identify impaired cardiac relaxation and related dysfunction, as well as the MyoVista wavECG device that captures resting 12-lead ECG data. It also provides MyoVista Insights, a cloud platform for deploying AI-ECG algorithms across ECG hardware, serving clinical and diagnostic use cases.

Valuation — source: SEC EDGAR (first-party)
Price	$1.83
Market Cap	$6.67M
P/E Ratio	-0.3
EV / EBITDA	-0.3
Price / Book	2.21
Price / Sales	675.95
DCF Value (model)	$-64.70
DCF Upside vs Price	-3635.5%

Profitability & Growth — source: SEC EDGAR
Revenue (TTM)	$4350.00
Net Margin	-201499.5%
Return on Equity	-319.9%
Current Ratio	1.19
Revenue Growth (YoY)	-76.6%
EPS Growth (YoY)	-50.8%
FCF Growth (YoY)	20.9%

Financial Health — source: SEC EDGAR
Altman Z-Score	-31.67 (distress)

Valuation vs Sector & Industry
Stock P/E	-0.3
Sector P/E (Healthcare)	20.9
Industry P/E (Medical Equipment)	31.7
vs Sector	-101.3%
vs Industry	-100.9%

Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional Holder	TFB Advisors LLC ($74766.00)
Institutional Holders Tracked	10

Company
Sector	Healthcare
Industry	Medical Equipment
CEO	Andrew Simpson
Employees	15
Country	US
IPO Date	2022-06-16

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.